{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T19:46:56Z","timestamp":1778960816467,"version":"3.51.4"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Neurodegenerative diseases are one of the most important contributors to morbidity and mortality in the elderly. In Europe, over 14 million people are currently living with dementia, at a cost of over 400 billion EUR annually. Recent advances in diagnostics and approval for new pharmaceutical treatments for Alzheimer\u2019s disease (AD), the most common etiology of dementia, heralds the beginning of precision medicine in this field. However, their implementation will challenge an already over-burdened healthcare systems. There is a need for innovative digital solutions that can drive the related clinical pathways and optimize and personalize care delivery. Public-private partnerships are ideal vehicles to tackle these challenges. Here we describe the Innovative Health Initiative (IHI) public-private partnership project PROMINENT that has been initiated by connecting leading dementia researchers, medical professionals, dementia patients and their care partners with the latest innovative health technologies using a precision medicine based digital platform. The project builds upon the knowledge and already implemented digital tools from several collaborative initiatives that address new models for early detection, diagnosis, and monitoring of AD and other neurodegenerative disorders. The project aims to provide support to improvement efforts to each aspect of the care pathway including diagnosis, prognosis, treatment, and data collection for real world evidence and cost effectiveness studies. Ultimately the PROMINENT project is expected to lead to cost-effective care and improved health outcomes.<\/jats:p>","DOI":"10.3389\/fneur.2023.1175922","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T09:06:08Z","timestamp":1690967168000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Precision medicine in neurodegeneration: the IHI-PROMINENT project"],"prefix":"10.3389","volume":"14","author":[{"given":"Ashley","family":"Tate","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Su\u00e1rez-Calvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Ekelund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Eriksdotter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiesje M.","family":"Van Der Flier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Georges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miia","family":"Kivipelto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milica G.","family":"Kramberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lindgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Domingo Gispert","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyrki","family":"L\u00f6tj\u00f6nen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofie","family":"Persson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Pla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennart","family":"Thurfjell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Wimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt","family":"Winblad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linus","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the PROMINENT consortium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","article-title":"Defeating Alzheimer's disease and other dementias: a priority for European science and society","volume":"15","author":"Winblad","year":"2016","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/alz.12694","article-title":"Global estimates on the number of persons across the Alzheimer's disease continuum","volume":"19","author":"Gustavsson","year":"2022","journal-title":"Alzheimers Dement"},{"key":"ref3","first-page":"e696","volume-title":"Global status report on the public health response to dementia","year":"2021"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","article-title":"Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials","volume":"21","author":"Ossenkoppele","year":"2022","journal-title":"Lancet Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e12295","DOI":"10.1002\/trc2.12295","article-title":"Alzheimer's disease drug development pipeline: 2022","volume":"8","author":"Cummings","year":"2022","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.7249\/RR2503","article-title":"Assessing the preparedness of the health care system infrastructure in six European countries for an Alzheimer's treatment","volume":"8","author":"Hlavka","year":"2019","journal-title":"Rand Health Q"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e12189","DOI":"10.1002\/trc2.12189","article-title":"Identifying relevant outcomes in the progression of Alzheimer's disease; what do patients and care partners want to know about prognosis?","volume":"7","author":"Mank","year":"2021","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.nicl.2016.02.019","article-title":"Differential diagnosis of neurodegenerative diseases using structural MRI data","volume":"11","author":"Koikkalainen","year":"2016","journal-title":"Neuroimage Clin"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/1567205016666190103152425","article-title":"Impact of a clinical decision support tool on dementia diagnostics in memory clinics: the PredictND validation study","volume":"16","author":"Bruun","year":"2019","journal-title":"Curr Alzheimer Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer's disease: recommendations of the international working group","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jalz.2019.02.003","article-title":"The MOPEAD project: advancing patient engagement for the detection of \u201chidden\u201d undiagnosed cases of Alzheimer's disease in the community","volume":"15","author":"Rodr\u00edguez-G\u00f3mez","year":"2019","journal-title":"Alzheimers Dement"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.3389\/fneur.2021.733878","article-title":"Design and development of a Mobile health (mHealth) platform for dementia prevention in the prevention of dementia by Mobile phone applications (PRODEMOS) project","volume":"12","author":"Hafdi","year":"2021","journal-title":"Front Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e046949","DOI":"10.1002\/alz.046949","article-title":"EURO-FINGERS\/UK FINGERS (Europe) world-wide FINGERS network: the first global network of multidomain dementia prevention trials","volume":"16","author":"Solomon","year":"2020","journal-title":"Alzheimers Dement"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/hex.13246","article-title":"Conducting public involvement in dementia research: the contribution of the European working Group of People with dementia to the ROADMAP project","volume":"24","author":"Diaz","year":"2021","journal-title":"Health Expect"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1140722","DOI":"10.3389\/fneur.2023.1140722","article-title":"Participating in innovative medicines initiative funded neurodegenerative disorder projects\u2014an impact analysis conducted as part of the NEURONET project","volume":"14","author":"Hawksworth","year":"2023","journal-title":"Front Neurol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1017\/S1041610217000552","article-title":"Exploring dementia management attitudes in primary care: a key informant survey to primary care physicians in 25 European countries","volume":"29","author":"Petrazzuoli","year":"2017","journal-title":"Int Psychogeriatr"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1031091","DOI":"10.3389\/fneur.2022.1031091","article-title":"Data and sample sharing as an enabler for large-scale biomarker research and development: the EPND perspective","volume":"13","author":"Bose","year":"2022","journal-title":"Front Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e12401","DOI":"10.1002\/trc2.12401","article-title":"Rationale and design of the ABOARD project (a personalized medicine approach for Alzheimer's disease)","volume":"9","author":"Dreves","year":"2023","journal-title":"Alzheimer Dement Trans Res Clin Intervent"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"631770","DOI":"10.3389\/fnagi.2021.631770","article-title":"The impact of disease comorbidities in Alzheimer's disease","volume":"13","author":"Santiago","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/s41591-022-01822-2","article-title":"Performance of plasma phosphorylated tau 181 and 217 in the community","volume":"28","author":"Mielke","year":"2022","journal-title":"Nat Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/alz.12444","article-title":"Aducanumab: appropriate use recommendations","volume":"18","author":"Cummings","year":"2022","journal-title":"Alzheimers Dement"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e0116538","DOI":"10.1371\/journal.pone.0116538","article-title":"SveDem, the Swedish dementia registry - a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice","volume":"10","author":"Religa","year":"2015","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-022-00979-9","article-title":"Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer\u2019s disease: a potential early sign of AD","volume":"14","author":"Goikolea","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-018-2013-9","article-title":"Kuopio birth cohort\u2013design of a Finnish joint research effort for identification of environmental and lifestyle risk factors for the wellbeing of the mother and the newborn child","volume":"18","author":"Huuskonen","year":"2018","journal-title":"BMC Preg Childbirth"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.trci.2016.02.003","article-title":"The ALFA project: a research platform to identify early pathophysiological features of Alzheimer's disease","volume":"2","author":"Molinuevo","year":"2016","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.14283\/jpad.2023.11","article-title":"Screening over speech in unselected populations for clinical trials in AD (PROSPECT-AD): study design and protocol","volume":"10","author":"K\u00f6nig","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12674","article-title":"Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers","author":"Jessen","year":"2022","journal-title":"Alzheimers Dement"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13195-017-0288-0","article-title":"Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort","volume":"9","author":"Dufouil","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1002\/alz.079187","article-title":"REAL AD - a realistic screening approach for preclinical Alzheimer\u2019s disease","author":"Blennow","year":"2023"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3233\/JAD-170850","article-title":"Amsterdam dementia cohort: performing research to optimize care","volume":"62","author":"Van Der Flier","year":"2018","journal-title":"J Alzheimers Dis"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1175922\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T14:43:59Z","timestamp":1729867439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1175922\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":31,"alternative-id":["10.3389\/fneur.2023.1175922"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1175922","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,2]]},"article-number":"1175922"}}